logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 9
  • 1
    Greig, Russell George, Dr
    Born in June 1952
    Individual (1 offspring)
    Officer
    2023-09-06 ~ now
    OF - Director → CIF 0
  • 2
    Hepple, Jonathan Paul, Dr
    Born in April 1971
    Individual (12 offsprings)
    Officer
    2020-11-30 ~ now
    OF - Director → CIF 0
  • 3
    Ishnazarova, Nadiya, Dr
    Born in June 1992
    Individual (1 offspring)
    Officer
    2025-12-04 ~ now
    OF - Director → CIF 0
  • 4
    Bodmer, Mark
    Born in June 1957
    Individual (1 offspring)
    Officer
    2024-07-24 ~ now
    OF - Director → CIF 0
  • 5
    Hughes, James Raymond
    Born in September 1968
    Individual (1 offspring)
    Officer
    2019-07-17 ~ now
    OF - Director → CIF 0
  • 6
    Anninga, Bauke, Dr
    Born in December 1986
    Individual (4 offsprings)
    Officer
    2022-10-21 ~ now
    OF - Director → CIF 0
  • 7
    Al-hallaq, Rana Abdul Raouf, Dr
    Born in June 1975
    Individual (2 offsprings)
    Officer
    2022-10-21 ~ now
    OF - Director → CIF 0
  • 8
    Davis, John
    Born in March 1962
    Individual (3 offsprings)
    Officer
    2024-02-15 ~ now
    OF - Director → CIF 0
  • 9
    OXFORD SCIENCES INNOVATION PLC - 2021-09-30
    OXFORD SCIENCES PLC - 2015-03-17
    46, Woodstock Road, Oxford, United Kingdom
    Active Corporate (12 parents, 58 offsprings)
    Person with significant control
    2019-08-02 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased 6
  • 1
    Maclaughlin, Fiona Caroline, Dr
    Born in April 1971
    Individual (3 offsprings)
    Officer
    2022-10-21 ~ 2025-12-04
    OF - Director → CIF 0
  • 2
    Jeziorska, Danuta Mariola, Dr
    Ceo born in June 1985
    Individual (2 offsprings)
    Officer
    2019-08-02 ~ 2024-04-19
    OF - Director → CIF 0
  • 3
    Johnson, Emma
    Born in June 1996
    Individual (1 offspring)
    Officer
    2023-03-02 ~ 2025-12-04
    OF - Director → CIF 0
  • 4
    Boyd, Phil
    Individual
    Officer
    2022-10-21 ~ 2024-07-26
    OF - Secretary → CIF 0
  • 5
    James Raymond Hughes
    Born in September 1968
    Individual (1 offspring)
    Person with significant control
    2019-07-17 ~ 2019-07-29
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
  • 6
    Mackinnon, Lachlan Tom
    Director born in April 1993
    Individual (2 offsprings)
    Officer
    2019-08-02 ~ 2020-10-16
    OF - Director → CIF 0
parent relation
Company in focus

NUCLEOME THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Average Number of Employees
42019-07-17 ~ 2020-07-31
02018-07-17 ~ 2019-07-16
Intangible Assets
77,056 GBP2020-07-31
Property, Plant & Equipment
126,464 GBP2020-07-31
Fixed Assets
203,520 GBP2020-07-31
Debtors
Current
126,258 GBP2020-07-31
Cash at bank and in hand
4,379,889 GBP2020-07-31
Current Assets
4,506,147 GBP2020-07-31
Creditors
Current, Amounts falling due within one year
-50,596 GBP2020-07-31
Net Current Assets/Liabilities
4,455,551 GBP2020-07-31
Total Assets Less Current Liabilities
4,659,071 GBP2020-07-31
Net Assets/Liabilities
4,659,071 GBP2020-07-31
Equity
Called up share capital
552 GBP2020-07-31
Share premium
5,200,760 GBP2020-07-31
Retained earnings (accumulated losses)
-542,241 GBP2020-07-31
Equity
4,659,071 GBP2020-07-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
80,757 GBP2020-07-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
3,701 GBP2020-07-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
77,056 GBP2020-07-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
109,879 GBP2020-07-31
Computers
37,522 GBP2020-07-31
Property, Plant & Equipment - Gross Cost
147,401 GBP2020-07-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
14,569 GBP2019-07-17 ~ 2020-07-31
Owned/Freehold
20,937 GBP2019-07-17 ~ 2020-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
14,569 GBP2020-07-31
Computers
6,368 GBP2020-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
20,937 GBP2020-07-31
Property, Plant & Equipment
Plant and equipment
95,310 GBP2020-07-31
Computers
31,154 GBP2020-07-31
Other Debtors
Current
32,591 GBP2020-07-31
Prepayments/Accrued Income
Current
8,247 GBP2020-07-31
Amount of corporation tax that is recoverable
Current
85,420 GBP2020-07-31
Cash and Cash Equivalents
4,379,889 GBP2020-07-31
Trade Creditors/Trade Payables
Current
30,027 GBP2020-07-31
Taxation/Social Security Payable
Current
9,595 GBP2020-07-31
Other Creditors
Current
974 GBP2020-07-31
Accrued Liabilities/Deferred Income
Current
10,000 GBP2020-07-31
Creditors
Current
50,596 GBP2020-07-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
5,200,000 shares2020-07-31
Par Value of Share
Class 1 ordinary share
0.000012019-07-17 ~ 2020-07-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
5,000,000 shares2020-07-31
Par Value of Share
Class 2 ordinary share
0.000102019-07-17 ~ 2020-07-31
  • NUCLEOME THERAPEUTICS LIMITED
    Info
    Registered number 12109297
    Nucleome Therapeutics Limited, Inventa, Botley Road, Oxford OX2 0HA
    PRIVATE LIMITED COMPANY incorporated on 2019-07-17 (6 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-16
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.